Local
Caliway's CBL-514 Receives Early IND Clearance in China, Accelerating Development in the World's Fastest-Growing Body Contouring Market
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: The Floyd County Times

China Clinical Trial Cleared Ahead of Schedule—CBL-514's China clinical study (CBL-0102) received authorization to proceed from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) ahead of the anticipated timeline, reflecting regulatory recognition of the study…
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at The Floyd County Times



